Smoking-associated lung cancer accounts for 81% (101,300 cases) of projected lung cancer mortality in 2024, while non-smoking-related etiologies contribute approximately 20,300 fatalities, encompassing environmentally induced subtypes and genetically driven variants such as EGFR-mutant adenocarcinomas (4). The gene discussed is EGFR; the disease is lung carcinoma.